Clinical Trial: Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure
Study Status: No longer available
Recruit Status: No longer available
Study Type: Expanded Access
Official Title: Expanded Access to MGAWN1 in Subjects With: Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection and a Compromised Immune System; or Substantial
Brief Summary: This study will test an experimental drug called MGAWN1 for the treatment of West Nile infections.
Detailed Summary: The objective of this study is to provide expanded access to MGAWN1; the study is not intended for subjects who are eligible for and have access to non-expanded access protocols.
Sponsor: MacroGenics
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: MacroGenics
Dates:
Date Received: September 17, 2010
Date Started:
Date Completion:
Last Updated: July 5, 2011
Last Verified: July 2011